Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2000
06/29/2000WO2000037450A1 NEW β-AMIDE AND β-SULFONAMIDE CARBOXYLIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS
06/29/2000WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia
06/29/2000WO2000037074A1 Mutilin 14-ester derivatives having antibacterial activity
06/29/2000WO2000037026A1 Dihydropyrimidines and uses thereof
06/29/2000WO2000036918A1 Methods and compositions for treatment of cell proliferative disorders
06/29/2000WO2000023447B1 Adenosine analogues having antihypertensive, cardioprotective, anti-ischemic antilipolytic properties
06/29/2000WO2000012497A3 Quinazoline derivatives as medicaments
06/29/2000WO2000009112A3 Heterocyclic esters or amides for vision and memory disorders
06/29/2000WO2000002887A3 Ligands for metals and metal-catalyzed processes
06/29/2000WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS
06/29/2000CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia
06/29/2000CA2355861A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands
06/29/2000CA2355848A1 Dihydropyrimidines and uses thereof
06/29/2000CA2355251A1 New .beta.-amide and .beta.-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists
06/29/2000CA2355137A1 Non-peptide nk1 receptors antagonists
06/29/2000CA2354779A1 Tricyclic farnesyl protein transferase inhibitors
06/29/2000CA2354511A1 Il-5 inhibiting 6-azauracil derivatives
06/28/2000EP1013276A1 Aminoazacycloalkanes as CCR5 modulators
06/28/2000EP1012166A1 1-amino-7-isoquinoline derivatives as serine protease inhibitors
06/28/2000EP1012164A1 Serine protease inhibitors
06/28/2000EP1012150A1 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders
06/28/2000EP1012144A1 Method for producing (hetero)aromatic hydroxylamines
06/28/2000EP1011667A1 Antagonists of gonadotropin releasing hormone
06/28/2000CN1258301A Antiviral protease inhibitors
06/28/2000CN1258296A Pyridine derivatives and pharmaceutical compositions contg. them
06/28/2000CN1258295A Novel form of S-omeprazole
06/28/2000CN1258294A 2-oxoimidazole derivs.
06/28/2000CN1258293A Substd. 2-(2,6-dioxopiperidin-3-yl)-phthalimides and 1-oxoisoindolines and method of reducing TNF 'alpha' levels
06/28/2000CN1258283A Cyclic diamine compounds and medicine contg. same
06/28/2000CN1258282A Parasiticidal pyrazoles
06/28/2000CN1257864A Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same
06/28/2000CN1257863A Sterically hindered amine compound
06/28/2000CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them
06/28/2000CN1053895C Substd. sulfonic acid amide, preparation process and pharmaceutical composition of same
06/28/2000CN1053894C Process for preparing 4,4'-bipyridyl
06/27/2000US6080873 Fused pyrrolecarboxamides; a new class of GABA brain receptor ligands
06/27/2000US6080871 Sulfonamides and sulfamides as H3 receptor antagonists
06/27/2000US6080867 Imidation and cyclization to form a chemical intermediate for making highly potent, environmentally benign, imidazoline herbicidal agents
06/27/2000US6080866 A chemical intermediates for endothelin receptor antagonists
06/27/2000US6080839 Labeling reactants and their use
06/27/2000US6080784 A phorbol derivative used as antiinflammatory agent
06/27/2000US6080775 Plant safening agent; preferably used as fungicide
06/27/2000US6080769 Imidazolidin-4-one derivatives useful as anticancer agents
06/27/2000US6080767 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/27/2000US6080763 Inhibit the release of inflammatory cytokines, e.g., tumor necrosis factor and interleukin-1; useful to treat chronic inflammatory disease; autoimmune diseases, e.g. rheumatoid arthritis, osteoporosis; pyrazolylureas
06/27/2000US6080758 Analgesics, antiinflammatory agents; asthma; allergic rhinitis
06/27/2000US6080757 Treatment of helicobacter (campylobacter) pylori infections; treatment and prevention of peptic ulcers, gastritis, dyspepsia, and gastric cancer
06/27/2000US6080745 For treating or preventing disorders of dopamine system, such as schizophrenia
06/27/2000US6080743 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
06/27/2000CA2188427C Neurotransmitter release enhancers
06/27/2000CA2017193C N-(aryloxyalkyl)heteroarylpiperidines and-heteroarylpiperazines, a pro cess for their preparation and their use as medicaments
06/22/2000WO2000035915A1 Piperazine derivatives
06/22/2000WO2000035908A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
06/22/2000WO2000035907A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
06/22/2000WO2000035906A2 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
06/22/2000WO2000035887A2 Vitronectin receptor antagonist pharmaceuticals
06/22/2000WO2000035886A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
06/22/2000WO2000035885A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000WO2000035884A1 Control of arthropods in animals
06/22/2000WO2000035878A1 1,4-piperazine derivatives having 5ht1a receptor activity
06/22/2000WO2000035877A1 Heterocyclic piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035876A1 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
06/22/2000WO2000035875A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
06/22/2000WO2000035874A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
06/22/2000WO2000035865A2 Tubulin-binding agents
06/22/2000WO2000035864A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000WO2000035492A2 Vitronectin receptor antagonist pharmaceuticals
06/22/2000WO2000035488A2 Vitronectin receptor antagonist pharmaceuticals
06/22/2000WO2000035454A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035453A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035452A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035451A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000035449A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000WO2000009487A9 Near infrared chemiluminescent acridinium compounds and uses thereof
06/22/2000CA2727746A1 Quinolone vitronectin receptor antagonist pharmaceuticals
06/22/2000CA2355249A1 Protease inhibitors
06/22/2000CA2355202A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
06/22/2000CA2355161A1 Biphenyl and biphenyl-analogous compounds as integrin antagonists
06/22/2000CA2354875A1 Piperazine derivatives
06/22/2000CA2354873A1 4-alkenyl (and alkynyl) oxindoles as inhibitors of cyclin-dependent kinases, in particular cdk2
06/22/2000CA2354510A1 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
06/22/2000CA2354061A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5ht1a receptor activity
06/22/2000CA2353924A1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
06/22/2000CA2351859A1 1,4-piperazine derivatives having 5ht1a receptor activity
06/22/2000CA2351400A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity
06/22/2000CA2350730A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2349501A1 Quinolone vitronectin receptor antagonist pharmaceuticals
06/22/2000CA2349333A1 Vitronectin receptor antagonist pharmaceuticals
06/22/2000CA2348923A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2347912A1 Heterocyclic piperidines as modulators of chemokine receptor activity
06/22/2000CA2347909A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2347770A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/22/2000CA2347769A1 2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
06/22/2000CA2346935A1 Vitronectin receptor antagonist pharmaceuticals
06/22/2000CA2346933A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
06/21/2000EP1010693A1 Imidazoline derivatives, preparation and pharmaceutical compositions containing them
06/21/2000EP1010691A2 Hydrazide derivatives, process for their preparation and pharmaceutical compositions containing them
06/21/2000EP1010423A2 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production
06/21/2000EP1009854A1 A method of treating cancer
06/21/2000EP1009758A1 Meta-benzamidine derivatives as serine protease inhibitors
1 ... 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 ... 1080